Iron loading impairs lipoprotein lipase activity and promotes hypertriglyceridemia

FASEB Journal

Volumn 27, Issue 4, 2013, Pages 1657-1663

  Kim, Jonghan ^a   Jia, Xuming ^a   Buckett, Peter D ^a   Liu, Sihao ^a   Lee, Chih Hao ^a   Wessling Resnick, Marianne ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Belgrade rat; Divalent metal transporter 1; Iron overload

Indexed keywords

CARBONYL IRON; IRON; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; ENZYME ACTIVITY; EX VIVO STUDY; FISCHER 344 RAT; HYPERTRIGLYCERIDEMIA; IN VITRO STUDY; IRON BLOOD LEVEL; LIPID METABOLISM; LIVER FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; RISK; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; DISEASE MODELS, ANIMAL; HYPERTRIGLYCERIDEMIA; IRON; LIPOPROTEIN LIPASE; LIVER; RATS; RATS, INBRED F344; TRIGLYCERIDES;

RATTUS;

EID: 84875724788     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-224386     Document Type: Article

References (50)

1. Fumeron, F., Pean, F., Driss, F., Balkau, B., Tichet, J., Marre, M., and Grandchamp, B. (2006) Ferritin and transferrin are both predictive of the onset of hyperglycemia in men and women over 3 years: the data from an epidemiological study on the Insulin Resistance Syndrome (DESIR) study. Diabetes Care 29, 2090-2094.
2. Sun, L., Franco, O. H., Hu, F. B., Cai, L., Yu, Z., Li, H., Ye, X., Qi, Q., Wang, J., Pan, A., Liu, Y., and Lin, X. (2008) Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J. Clin. Endocrinol. Metab. 93, 4690-4696.
3. Vari, I. S., Balkau, B., Kettaneh, A., Andre, P., Tichet, J., Fumeron, F., Caces, E., Marre, M., Grandchamp, B., and Ducimetiere, P. (2007) Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 30, 1795-1801.
4. Casanova-Esteban, P., Guiral, N., Andres, E., Gonzalvo, C., Mateo-Gallego, R., Giraldo, P., Paramo, J. A., and Civeira, F. (2011) Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Metabolism 60, 830-836.
5. Bofill, C., Joven, J., Bages, J., Vilella, E., Sans, T., Cavalle, P., Miralles, R., Llobet, J., and Camps, J. (1994) Response to repeated phlebotomies in patients with non-insulin-dependent diabetes mellitus. Metabolism 43, 614-620.
6. Fernandez-Real, J. M., Penarroja, G., Castro, A., Garcia-Bragado, F., Hernandez-Aguado, I., and Ricart, W. (2002) Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes 51, 1000-1004.
7. Ford, E. S., and Cogswell, M. E. (1999) Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 22, 1978-1983.
8. Jiang, R., Manson, J. E., Meigs, J. B., Ma, J., Rifai, N., and Hu, F. B. (2004) Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 291, 711-717.
9. Salonen, J. T., Tuomainen, T. P., Nyyssonen, K., Lakka, H. M., and Punnonen, K. (1998) Relation between iron stores and non-insulin dependent diabetes in men: case-control study. BMJ 317, 727.
10. Solanas-Barca, M., Mateo-Gallego, R., Calmarza, P., Jarauta, E., Bea, A. M., Cenarro, A., and Civeira, F. (2009) Mutations in HFE causing hemochromatosis are associated with primary hypertriglyceridemia. J. Clin. Endocrinol. Metab. 94, 4391-4397.
11. Al-Quobaili, F. A., and Abou Asali, I. E. (2004) Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major. Saudi Med. J. 25, 871-875.
12. Fleming, M. D., Trenor, C. C., Su, M. A., Foernzler, D., Beier, D. R., Dietrich, W. F., and Andrews, N. C. (1997) Microcytic anaemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet. 16, 383-386.
13. Gunshin, H., Mackenzie, B., Berger, U. V., Gunshin, Y., Romero, M. F., Boron, W. F., Nussberger, S., Gollan, J. L., and Hediger, M. A. (1997) Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388, 482-488.
14. Fleming, M. D., Romano, M. A., Su, M. A., Garrick, L. M., Garrick, M. D., and Andrews, N. C. (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proc. Natl. Acad. Sci. U. S. A. 95, 1148-1153.
15. Thompson, K., Molina, R. M., Brain, J. D., and Wessling- Resnick, M. (2006) Belgrade rats display liver iron loading. J. Nutr. 136, 3010-3014.
16. Kim, J., Molina, R. M., Donaghey, T. C., Buckett, P. D., Brain, J. D., and Wessling-Resnick, M. (2011) Influence of DMT1 and iron status on inflammatory responses in the lung. Am. J. Physiol. Lung Cell. Mol. Physiol. 300, L659-665.
17. Mims, M. P., Guan, Y., Pospisilova, D., Priwitzerova, M., Indrak, K., Ponka, P., Divoky, V., and Prchal, J. T. (2005) Identification of a human mutation of DMT1 in a patient with microcytic anemia and iron overload. Blood 105, 1337-1342.
18. Iolascon, A., d'Apolito, M., Servedio, V., Cimmino, F., Piga, A., and Camaschella, C. (2006) Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood 107, 349-354.
19. Beaumont, C., Delaunay, J., Hetet, G., Grandchamp, B., de Montalembert, M., and Tchernia, G. (2006) Two new human DMT1 gene mutations in a patient with microcytic anemia, low ferritinemia, and liver iron overload. Blood 107, 4168-4170.
20. Cooksey, R. C., Jouihan, H. A., Ajioka, R. S., Hazel, M. W., Jones, D. L., Kushner, J. P., and McClain, D. A. (2004) Oxidative stress, beta-cell apoptosis, and decreased insulin secretory capacity in mouse models of hemochromatosis. Endocrinology 145, 5305- 5312.
21. Ramey, G., Faye, A., Durel, B., Viollet, B., and Vaulont, S. (2007) Iron overload in Hepc1 mice is not impairing glucose homeostasis. FEBS Lett. 581, 1053-1057.
22. Brunet, S., Thibault, L., Delvin, E., Yotov, W., Bendayan, M., and Levy, E. (1999) Dietary iron overload and induced lipid peroxidation are associated with impaired plasma lipid transport and hepatic sterol metabolism in rats. Hepatology 29, 1809-1817.
23. Silva, M., Silva, M. E., de Paula, H., Carneiro, C. M., and Pedrosa, M. L. (2008) Iron overload alters glucose homeostasis, causes liver steatosis, and increases serum triacylglycerols in rats. Nutr. Res. 28, 391-398.
24. Thompson, K., Molina, R., Donaghey, T., Brain, J. D., and Wessling-Resnick, M. (2006) The influence of high iron diet on rat lung manganese absorption. Toxicol. Appl. Pharmacol. 210, 17-23.
25. Thompson, K., Molina, R. M., Donaghey, T., Schwob, J. E., Brain, J. D., and Wessling-Resnick, M. (2007) Olfactory uptake of manganese requires DMT1 and is enhanced by anemia. FASEB J. 21, 223-230.
26. Heilig, E., Molina, R., Donaghey, T., Brain, J. D., and Wessling- Resnick, M. (2005) Pharmacokinetics of pulmonary manganese absorption: evidence for increased susceptibility to manganese loading in iron-deficient rats. Am. J. Physiol. Lung Cell. Mol. Physiol. 288, L887-893.
27. Chaudhury, C., Kim, J., Mehnaz, S., Wani, M. A., Oberyszyn, T. M., Bronson, C. L., Mohanty, S., Hayton, W. L., Robinson, J. M., and Anderson, C. L. (2006) Accelerated transferrin degradation in HFE-deficient mice is associated with increased transferrin saturation. J. Nutr. 136, 2993-2998.
28. Garrick, M., Scott, D., Walpole, S., Finkelstein, E., Whitbred, J., Chopra, S., Trivikram, L., Mayes, D., Rhodes, D., Cabbagestalk, K., Oklu, R., Sadiq, A., Mascia, B., Hoke, J., and Garrick, L. (1997) Iron supplementation moderates but does not cure the Belgrade anemia. Biometals 10, 65-76.
29. Sladic-Simic, D., Martinovitch, P. N., Zivkovic, N., Pavic, D., Martinovic, J., Kahn, M., and Ranney, H. M. (1969) A thalassemia- like disorder in Belgrade laboratory rats. Ann. N. Y. Acad. Sci. 165, 93-99.
30. Lewis, M., and Iammarino, R. M. (1971) Lipemia in rodent iron-deficiency anemia. J. Lab. Clin. Med. 78, 546-554.
31. Stangl, G. I., and Kirchgessner, M. (1998) Different degrees of moderate iron deficiency modulate lipid metabolism of rats. Lipids 33, 889-895.
32. Galan, P., Hercberg, S., and Touitou, Y. (1984) The activity of tissue enzymes in iron-deficient rat and man: an overview. Comp. Biochem. Physiol. B. 77, 647-653.
33. Davis, M. R., Rendina, E., Peterson, S. K., Lucas, E. A., Smith, B. J., and Clarke, S. L. (2012) Enhanced expression of lipogenic genes may contribute to hyperglycemia and alterations in plasma lipids in response to dietary iron deficiency. Genes Nutr. 7, 415-425.
34. Yamagishi, H., Okazaki, H., Shimizu, M., Izawa, T., and Komabayashi, T. (2000) Relationships among serum triacylglycerol, fat pad weight, and lipolysis in iron-deficient rats. J. Nutrit. Biochem. 11, 455-460.
35. Cooksey, R. C., Jones, D., Gabrielsen, S., Huang, J., Simcox, J. A., Luo, B., Soesanto, Y., Rienhoff, H., Abel, E. D., and McClain, D. A. (2010) Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep) mouse. Am. J. Physiol. Endocrin. Metabol. 298, E1236-1243.
36. Casanova-Esteban, P., Guiral, N., Andres, E., Gonzalvo, C., Mateo-Gallego, R., Giraldo, P., Paramo, J. A., and Civeira, F. (2011) Effect of phlebotomy on lipid metabolism in subjects with hereditary hemochromatosis. Metabolism 60, 830-834.
37. Wlazlo, N., and Greevenbroek, M. M. (2012) Lipid metabolism: a role for iron? Curr. Opin. Lipid. 23, 258-259.
38. Bell-Quint, J., Forte, T., and Graham, P. (1981) Synthesis of two forms of apolipoprotein B by cultured rat hepatocytes. Biochem. Biophys. Res. Commun. 99, 700-706.
39. Jones, A. L., Hradek, G. T., Hornick, C., Renaud, G., Windler, E. E., and Havel, R. J. (1984) Uptake and processing of remnants of chylomicrons and very low density lipoproteins by rat liver. J. Lipid Res. 25, 1151-1158.
40. Horonchik, L., and Wessling-Resnick, M. (2008) The smallmolecule iron transport inhibitor ferristatin/NSC306711 promotes degradation of the transferrin receptor. Chem. Biol. 15, 647-653.
41. Buckett, P. D., and Wessling-Resnick, M. (2009) Small molecule inhibitors of divalent metal transporter-1. Am. J. Physiol. Gastrointest. Liver Physiol. 296, G798-804.
42. Holm, C., Olivecrona, G., and Ottosson, M. (2001) Assays of lipolytic enzymes. Methods Mol. Biol. 155, 97-119.
43. Cherchi, G. M., Baggi, M. A., Coinu, R., Deiana, M. G., Pacifico, A., and Maioli, M. (1983) [Post-heparin lipase activity in betathalassemia major: preliminary data]. Boll. Soc. Ital. Biol. Sper. 59, 1739-1743.
44. Hartman, C., Tamary, H., Tamir, A., Shabad, E., Levine, C., Koren, A., and Shamir, R. (2002) Hypocholesterolemia in children and adolescents with beta-thalassemia intermedia. J. Pediatr. 141, 543-547.
45. Tantawy, A. A., Adly, A. A., El Maaty, M. G., and Amin, S. A. (2009) Subclinical atherosclerosis in young beta-thalassemia major patients. Hemoglobin 33, 463-474.
46. Papanastasiou, D. A., Siorokou, T., and Haliotis, F. A. (1996) beta-Thalassaemia and factors affecting the metabolism of lipids and lipoproteins. Haematologia (Budapest) 27, 143-153.
47. Nasr, M. R., Abdelmaksoud, A. M., Abd El-Aal, K. S., Mabrouk, N. A., and Ismael, W. M. (2008) Plasma lipid profile and lipid peroxidation in beta-thalassemic children. J. Clin. Lipidol. 2, 405-409.
48. Mateo-Gallego, R., Calmarza, P., Jarauta, E., Burillo, E., Cenarro, A., and Civeira, F. (2010) Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia. Metabolism 59, 154- 158.
49. Cutler, P. (1989) Deferoxamine therapy in high-ferritin diabetes. Diabetes 38, 1207-1210.
50. Byrne, S. L., Krishnamurthy, D., and Wessling-Resnick, M. (2013) Pharmacology of iron transport. Ann. Rev. Pharmacol. Toxicol. 53 In press.